Inhalational vs Intravenous Anesthesia for Surgery Patients
(TIVA GAS Trial)
Trial Summary
What is the purpose of this trial?
Traditionally, general anesthesia is maintained with inhalational anesthesia (GAS), but there is a gap in knowledge regarding whether intravenous anesthesia (IV) can prevent deleterious postoperative outcomes in the geriatric surgical population. The goal of this clinical trial is to determine whether intravenous anesthesia (IV) leads to a decreased incidence of postoperative delirium (POD), postoperative cognitive dysfunction (POCD), and functional decline, and improved patient-reported outcomes (PROs) in older adults undergoing non-cardiac surgery when compared to the standard inhalational anesthesia (GAS). This single-center, 1:1 randomized, double-blind (patient \& outcome assessor) clinical trial will compare inhalational vs. intravenous anesthesia on POD, POCD, functional status, patient-reported outcomes (PROs), and blood-based biomarkers in older patients undergoing elective, inpatient, non-cardiac surgery. Upon enrollment, 260 women and men ≥ 70 years undergoing elective noncardiac surgery under general anesthesia will be randomized to 2 groups: TIVA or GAS.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the drug Propofol, Sevoflurane, Sevorane, Ultane for surgery patients?
Is it safe to use inhalational or intravenous anesthesia in humans?
Research suggests that both inhalational (like sevoflurane) and intravenous (like propofol) anesthesia are generally safe, but they may have different risks. Intravenous anesthesia might have a lower risk of breathing problems, while inhalational anesthesia might be linked to fewer heart rate issues.16789
How does the drug Propofol differ from Sevoflurane in anesthesia?
Propofol is administered intravenously (through a vein) and is known for reducing postoperative vomiting and agitation, while Sevoflurane is inhaled and can shorten the duration of intubation and hospital stay. Each has unique benefits and drawbacks, such as Propofol's potential for injection pain and Sevoflurane's reduced cardiovascular side effects.110111213
Research Team
Katie Schenning, MD
Principal Investigator
Oregon Health and Science University
Eligibility Criteria
This trial is for men and women aged 75 or older who are proficient in English, scheduled for elective non-cardiac surgery lasting at least 2 hours under general anesthesia. They must have good vision and hearing, an informant to verify their cognitive status, and no recent surgeries. Excluded are those with urgent surgeries, certain medical conditions like dementia or major psychiatric diseases, allergies to the study drugs, or a history of substance abuse.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either intravenous or inhalational anesthesia during non-cardiac surgery
Immediate Postoperative Monitoring
Participants are monitored for delirium and cognitive dysfunction in the PACU and twice daily on postoperative days 1-3
Follow-up
Participants are monitored for cognitive and functional outcomes, and blood biomarkers are assessed at 3 months and 12 months postoperatively
Treatment Details
Interventions
- Propofol
- Sevoflurane
Find a Clinic Near You
Who Is Running the Clinical Trial?
Oregon Health and Science University
Lead Sponsor